AstraZeneca, GB0009895292

AstraZeneca stock heads into the open after a 0.08 percent fall

Published on 09/23/2026 at 07:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 21, 2026, AstraZeneca stock stood at GBP 124.90 after falling 0.08 percent, with 466,890 shares traded and a session range of GBP 123.64 to GBP 124.90.

Wissenschaftler im weißen Kittel arbeiten in modernem Pharma-Forschungslabor
AstraZeneca plc (ISIN GB0009895292) betreibt moderne Forschungslabore für pharmazeutische Wirkstoffentwicklung und klinische Studien weltweit, Illustration mit AI erstellt.

AstraZeneca stock closed at GBP 124.90 on the London Stock Exchange on September 21, 2026, down 0.08 percent.

September 21, 2026 in numbers

AstraZeneca plc (ISIN GB0009895292) traded between GBP 123.64 and GBP 124.90, with volume of 466,890 shares. The FTSE 100 closed at 10,708.33 on September 22, 2026, down 0.29 percent, providing the latest substantiated reference-market comparison.

Reuters reported on September 22, 2026, that AstraZeneca shares had fallen 9 percent in the session after a Financial Times report about discussions with Bristol Myers Squibb; the report said AstraZeneca rejected the prospect of a megamerger. MarketBeat reported on September 22, 2026, that AstraZeneca had a 12-month low of USD 145.79 and a 12-month high of USD 212.71 for its cited listing.

September 23, 2026 ahead of the open

European equity markets and pharmaceutical shares remain relevant market context for AstraZeneca today. The latest FTSE 100 close was 10,708.33, down 0.29 percent on September 22, 2026.

Disclaimer...

en | GB0009895292 | ASTRAZENECA | boerse | 70163082 | bgmi